Understanding psychosis: schizophrenia or drug-induced?
Part of Mental health clinical trials.
This study observes patients with psychosis to help tell if it is caused by schizophrenia or by methamphetamine use, so doctors can offer the right treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are experiencing active psychotic symptoms (like hallucinations or delusions).
- You have a diagnosis of either schizophrenia or methamphetamine-induced psychotic disorder (according to DSM-5 criteria).
- You do not have a major brain disorder (like epilepsy or dementia) or a serious medical illness that affects thinking.
- You are able to take part in an interview.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
This study compares people who have psychosis from methamphetamine and also use cannabis with those who only have methamphetamine-induced psychosis. It aims to understand how cannabis may affect their symptoms.
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
This study looks at two blood proteins (LRFN5 and OLFM4) in people with methamphetamine use disorder or methamphetamine-induced psychosis, compared to healthy controls. Results may help understand the biology of these conditions.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
This study follows people who were part of an earlier research trial about medication management during their first psychotic episode. Researchers want to understand how those early treatment choices affected their recovery over the past 20 years.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.